Consequences of altered Cacna1c and Cacna1d expression levels on CaV1.2 and CaV1.3 activity by McMahon, Justin
  
 
 
 
Consequences of altered Cacna1c and Cacna1d expression levels on CaV1.2 and CaV1.3 activity 
 
 
 
 
A thesis submitted in partial fulfillment of the Degree of  
Bachelor of Science in Neuroscience with Honors 
 
University of Michigan, Ann Arbor 
 
 
 
 
by 
Justin McMahon 
 
Co-sponsored by 
Geoffrey Murphy, PhD and Richard Hume, PhD 
 
 
 
 
April 1, 2020 
 
  
i 
 
Abstract 
L-type voltage-gated calcium channels (LVGCCs) play an important role in neuronal 
excitability. In the brain, CaV1.2 and CaV1.3 are the most predominately expressed LVGCCs. 
Genetic mutations of either of these LVGCCs have been shown to confer impairment in memory 
consolidation as well as increase risk for development of neuropsychiatric disorders. Therefore, 
we used in vitro calcium imaging to test the role of altered Cacna1c or Cacna1d expression 
levels on the underlying calcium dynamics. Additionally, we performed immunocytochemistry 
(ICC) to localize expression patterns of LVGCCs in hippocampal neuronal cultures. We show 
that genetic alterations of LVGCC expression levels may result in a potentially reciprocal 
mechanism of calcium activity. The characterization of CaV1.2 and CaV1.3 expression in 
neuronal cultures allows for future calcium imaging experiments with much higher spatial 
resolution.   
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Introduction 
General Overview 
Neuroscience is the study of the nervous system and its structural, biological, chemical, 
and psychological components. These components work together cohesively in order for us to 
perceive information and interact with our environment. In the human body, the brain and spinal 
cord make up the central nervous system – while the peripheral nervous system is composed of 
the nerves that branch out from the spinal cord to organs and muscles throughout the body. With 
the increasing popularity of neuroscience, research projects range from the discovery of 
individual proteins in mice to more translational initiatives such as behavioral studies of humans 
with neuropsychiatric disorders. These research projects work to develop our understanding of 
fundamental biological mechanisms which underpin daily human function. More than this, they 
strive to develop cutting-edge therapeutics which improve quality of life for neurologically 
impaired individuals across the globe. How is it that this tremendous goal of developing novel 
treatments for neurological disorders is being achieved? The story of therapeutic research is one 
which starts far before the onset of clinical trials. 
 Beginning with an idea, a group of scientists design a plan to answer a question. An 
appropriate animal model is selected to investigate based on the phenotype of interest. A 
phenotype refers to the observable characteristics of an organism caused by its genetics and 
surrounding environment. For instance, this could be a specific disease or malformation caused 
by an underlying genetic mutation. While the most scientifically ideal scenario would be to 
answer questions about these phenotypes based on experimental results in humans, the ethical 
component of science must be taken into consideration. As such, we commonly use animals – 
such as mice, rats, fruit flies, monkeys, or zebrafish – to model the specific mechanism we are 
interested in studying. Because a neuron functions similarly in humans and mice, we are often 
able to successfully study aspects of neuronal function without ever interfering with a human’s 
nervous system. Furthermore, in vitro culturing cells (that is, growing cells in a controlled 
artificial environment) in a dish has proven to be an effective strategy for studying physiological 
principles, given the easily controllable environment and genetic homogeneity among the cells 
within the culture. To fully comprehend the abstract idea of why looking at cells in a dish is 
2 
 
important for studying disorders like schizophrenia or bipolar disorder, we must look at the 
underlying biology. 
 In the field of neuropsychiatric disorders research, it is important to understand 
fundamental neuroscience principles when comprehending the implications of altered protein 
expression levels due to genetic mutations. There are approximately eighty-six billion neurons in 
the human brain, connected in meaningful ways so that we can have conscious thought, perceive 
sensory information, learn and form memories, and have a personality. When we zoom in on this 
bigger picture of complex neural circuity, we see that a set of neurons connected via synapses lie 
at the core of each neural circuit. Synapses are tiny gaps where chemical messages are 
transmitted between neurons to relay information. If one neuron is sufficiently stimulated at this 
gap, it will generate an electrical signal called an action potential which propagates from the cell 
body all the way to the end of the neuron. In the case of the sciatic nerve, these neurons can be 
up to one meter long in the human body!  
This communication between neurons is best defined as electrochemical, since both 
electrical and chemical mechanisms are necessary for synaptic transmission and action potential 
generation. This electrochemical communication is created by a gradient of electrically charged 
ions, and it is differences in these ion concentrations which make this system so effective. It 
takes about 1 millisecond for an action potential to occur, making this an incredibly precise – but 
nonetheless complex – process. Proteins are involved at every step, mediating the transport of 
ions and the overall electrochemical gradient of communication within and between neurons. 
These proteins form ion channels that can be specific for transporting particular ions across the 
cell membrane. For example, calcium channels have specificity for calcium ions, meaning that 
they are responsible for determining how high or low the concentration of calcium will be inside 
versus outside the neuron. Because calcium is involved in physiological processes such as 
neurotransmission, hormonal secretion, and gene expression, dysfunction in these calcium 
channels may result in abnormal behavioral phenotypes. 
Neuropsychiatric disorders consist of a wide array of symptoms ranging from intellectual 
disability to depression. Given these vast differences in symptomology, it makes sense that many 
different biological explanations are possible for a given neuropsychiatric disorder. However, 
despite the many proposed etiologies, most of these disorders are still not well understood. So, 
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what is it, exactly, that makes things like bipolar disorder, schizophrenia, and autism spectrum 
disorder so difficult to study? One of the largest challenges we face in studying these disorders is 
a concept in psychology called equifinality. Equifinality refers to the idea that multiple different 
factors can lead to the same disorder: factors like stress, genetic mutations, and socioeconomic 
status, among others. This adds a significant level of complexity to studying any one disorder, 
because there is likely to be wide variability from person to person in the way they develop a 
disorder. Furthermore, differences in the environmental conditions a person is surrounded with is 
also likely to contribute to variations in the onset of a neuropsychiatric disorder. These 
differences are difficult to recapitulate in a laboratory setting, but hope is not lost.  
 Over the past twenty years, genetics research has deepened our understanding of the way 
in which many disorders may or may not be inherited. It is known that 99.9% of our DNA is 
identical to one another, but the variability of the other 0.1% makes a huge difference for genetic 
diseases (Crow, 2002). Genome-wide association studies (GWAS) have been employed to 
identify specific genetic variations that are highly associated with given diseases. These studies 
work by analyzing the genome for variations which occur more frequently in people with a 
certain disease and compares them to people without that disease. Single-nucleotide 
polymorphisms (SNPs) are one type of genetic variation which have proven to serve an integral 
role in the genetic explanation for who is more at risk for developing a particular disease. A SNP 
is the result of a single nucleotide, or genetic building block, being substituted for another 
nucleotide in a person’s genetic code. Each person has approximately three billion nucleotides, 
so why does a change in just one lead to the potential of developing a serious, sometimes fatal, 
disease? And moreover, how can we use these identified SNPs to better understand the biology 
underneath a specific illness? 
 Most psychiatric disorders are polygenic, meaning that many genes contribute to the 
onset of one disorder. However, if we are able to identify even just one of the many possible 
SNPs associated with a certain disorder, we can use that information to learn more about what 
that specific genetic mutation does to the human body. For example, consider a SNP in a gene 
which is found to be associated with high risk for developing fragile X syndrome. Upon closer 
investigation, it is discovered that this particular mutation occurs on a gene that normally codes 
for a protein called fragile X mental retardation protein (FMRP). This protein is essential for 
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normal brain development, as it plays a role in how neurons are connected to each other. As a 
result of this single gene mutation, the individual is not able to make enough FMRP and thus can 
go on to develop severe intellectual disability, abnormal speech patterns, and even increased 
anxiety (Myrick et al., 2015). Fragile X syndrome is a prominent example of how a SNP can 
indicate associated risk for development of a life-altering disease. However, fragile X syndrome 
is a monogenic disease, meaning the development is attributed to mutations in only one gene. 
This is a rare scenario, but it highlights the way which the identification of SNPs can help us to 
study diseases. In addition to multiple genes giving rise to a single disease, the opposite may also 
occur: pleiotropy is the phenomenon which refers to a single gene producing several phenotypes. 
As such, studying the biological effects of even one SNP often helps further the understanding of 
how multiple different diseases function. 
To draw the connection between identified SNP and biological consequence, there are 
several steps that must be taken in the laboratory. First, we must know the genomic region where 
the SNP is located. At this point, there are two possibilities: the SNP is located in a region of 
DNA which codes for a specific protein, or the SNP is located in a region of DNA that does not 
code for a specific protein. The latter case is much more difficult to study, because there is much 
more variability in the effect this mutation could have on the rest of the genome. If we have a 
SNP in a DNA region which does code for a known protein (i.e. the first scenario) we can then 
design an animal model to study how that SNP affects the protein of interest. More specifically, 
we can develop a model organism in which only that single nucleotide is substituted, then see if 
there are resulting biological differences between this mutated model compared to a normal 
organism. This technique of fine-tuned genetic manipulation is called transgenesis, and the 
individual gene being mutated is called the transgene. If we manipulate a gene in a mouse model 
to create a transgenic mouse, we can then determine if the mutation results in a change in the 
protein compared to the normal, non-transgenic, mouse. Once we know how the protein 
expression levels are affected, the next step is to see how this altered protein level affects cellular 
processes. Depending on the protein of interest, this could result in severe dysfunction of 
biochemical mechanisms underlying multiple different diseases. 
A recent GWAS found a SNP located near the CACNA1C gene to be associated with 
increased risk for multiple different psychiatric diseases (Smoller et al., 2013). This gene 
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encodes for part of a protein called CaV1.2, a subtype of calcium channel which controls the 
cellular concentration levels of calcium ions involved with a neuron’s decision to fire an action 
potential (Deisseroth et al., 1996). The SNP mutation in this gene has been shown to alter the 
sensitivity level of CaV1.2 in a way that may confer abnormally high calcium concentration 
levels inside the cell (Bhat et al., 2012). A SNP also exists on the CACNA1D gene, which codes 
for another calcium channel called CaV1.3. Similar to the SNP near the CACNA1C gene, the 
CACNA1D mutation is associated with increased risk for developing a neuropsychiatric disorder 
(Ross et al., 2016a). Mutations in Cacna1c and Cacna1d have also each been shown to cause 
memory impairment in mouse models (McKinney and Murphy, 2006a; White et al., 2008). 
However, the changes in calcium dynamics that result from these heritable genetic mutations 
have yet to be fully characterized. Due to the demonstrated importance of CaV1.2 and CaV1.3 in 
multiple neural circuits, it is valuable to understand how calcium concentrations are affected by 
these mutations. 
To investigate changes in calcium dynamics, we make use of a technique called in vitro 
calcium imaging. In this method of visualizing calcium activity, a bioluminescent molecule 
derived from luminescent jellyfish – called aequorin – fluoresces green when it comes into 
contact with a calcium ion (Shimomura et al., 1962). The brighter the green light glows in a 
given cell, the more calcium present. By comparing calcium dynamics of neurons containing the 
SNP linked to altered CaV1.2 or CaV1.3 functionality to the calcium dynamics of non-mutated 
neurons, we can develop the understanding of how this mutation might contribute to 
neuropsychiatric disorders. 
 
Critical Literature Review  
Genetic research advancements for neuropsychiatric disorders 
Over the past thirty years, substantial progress been made in the field of genetics 
pertaining to neurological and psychiatric disease states. In 1983, Huntington’s disease (HD) 
became the first mapped human genetic disease (Gusella et al., 1983). To accomplish this, 
scientists established large family studies and analyzed polymorphic DNA markers linked to HD. 
As a result, they were able to localize the mutation to chromosome 4. It was not until 1993, 
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however, that the genetic mutation resulting in HD development was isolated further to 
chromosome 4p16.3  (MacDonald et al., 1993). Even after defining the genetic locus of HD 
using positional cloning, MacDonald et al. were not able to specify affected biological 
mechanisms resulting from the mutation in the HTT gene. In fact, the role of Huntingtin protein, 
the product of HTT transcription and translation, remains unknown (Moldovean and Chiş, 2020).  
 The story of HD research is a motivating one, because it resembles the advancements the 
field has made in elucidating the biological underpinnings for a given disease. Since the 
discovery of the genetic locus for HD, many diseases have shared a similar narrative – owing 
their success to high-throughput sequencing and the development of genomic comparison 
studies. However, it is uncommon that a disease is monogenic like HD. Usually, a given disease 
phenotype is multifactorial, with multiple mutations located at different regions throughout the 
genome. Understanding the physiological effects of even one of these mutations allows 
researchers to more holistically characterize a disorder, with the hope of eventually developing 
an effective therapeutic treatment. Since the discovery of HTT as the first disease gene, genetic 
tools have become much more advanced in identifying high risk-associated loci.  
Rather than relying on a particular family pedigree and linkage analysis to identify a 
locus for a disease gene, a genome-wide association study (GWAS) uses markers across the 
genome to investigate association between particular genes and a given phenotype of interest. 
The first GWAS was published in 2002 (Ozaki et al., 2002), and since then then use of single-
nucleotide polymorphisms (SNPs) have advanced the study of genetic mutations that hold high 
potential for causing a particular disease. As the name suggests, a SNP refers to a point mutation. 
Often, a SNP will occur within or near a gene, in which case there is increased potential for that 
mutation to have a direct effect on the biological mechanisms associated with that given gene. 
An advantage of conducting a GWAS over a linkage analysis it the unbiased nature of a GWAS, 
since it is essentially hypothesis-free. Because GWA studies screen a population of affected 
individuals, they have much higher genetic resolution than a pedigree-based linkage analysis. 
Since a GWAS assumes individuals are not related, a high-risk SNP may be more tightly linked 
to genetic contribution in disease etiology than in a family linkage study. 
For many years, twin concordance studies have suggested that disorders such as autism, 
schizophrenia, and bipolar disorder are highly heritable (Folstein and Rutter, 1977; McGuffin et 
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al., 1984, 2003). More recently, GWA studies have shed light on specific heritable mutations 
associated with increased risk for development of neuropsychiatric disorders. As such, these 
advancements have given rise to research projects aimed at understanding mechanisms by which 
genetic mutations may contribute to pathological phenotypes. Once a SNP has been marked as 
having high association with a certain disorder via GWA studies, subsequent research of that 
disorder is then able to be conducted with a much finer lens. For this reason, calcium channels 
have been of increasing interest in the field, as mutations in these proteins have been identified 
as significant biological underpinnings implicated in many diseases and behavioral 
abnormalities.  
 
Introduction to calcium channels 
Calcium is a fundamental signaling molecule that mediates neurotransmission, hormonal 
secretion, gene expression, and muscle contraction, among other physiological processes. 
Without calcium channels, many of these processes would not be possible. As such, disruptions 
in normal calcium signaling can have severe repercussions in terms of health and well-being.  
  Calcium channels are a class of ion channels with selective permeability to calcium ions 
(Ca2+). There are two main superfamilies of calcium channels: ligand-gated calcium channels, 
and voltage-gated calcium channels (VGCCs). It is important to note that these are not the only 
ion channels capable of transmitting calcium across the cell membrane, as non-selective cation 
channels such as transient receptor potential (TRP) channels also play a key role in this process. 
However, ligand-gated calcium channels and VGCCs function in a Ca2+-specific manner and 
will thus be the focus of this discussion.  
Ligand-gated calcium channels form a group of transmembrane proteins which rely on 
the detection of a chemical messenger (ligand) to open and allow the passage of Ca2+ ions 
through the cellular membrane. These calcium channels, also known as ionotropic receptors, 
tend to localize on or around the postsynaptic neuronal membrane. Here, neurochemical 
messenger molecules (neurotransmitters) bind to these receptor channels and cause a 
conformational change. This structural change opens the channel for Ca2+ ions to pass through, 
effectively transmitting information from the presynaptic terminal to the postsynaptic neuron. 
Drugs used to suppress the cough reflex, such as dextromethorphan, target a type of ligand-gated 
ion channel called N-methyl-D-aspartate (NMDA) receptors, which are permeable to not only 
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Ca2+ but also sodium (Na+) and potassium (K+) ions (Ascher and Nowak, 1987). Non-
competitive receptor antagonists like dextromethorphan work by binding to an allosteric site on 
these ligand-gated channels to prevent receptor activation. Pharmacological interventions like 
this are useful in the treatments of many medical ailments, as they capitalize on the 
comprehension that investigative research has provided about these ligand-gated ion channels.  
While ligand-gated ion channels are important components of normal cell function, 
VGCCs are directly involved in transducing membrane potential changes to make cellular 
communication possible. The imperative nature of VGCCs in neurotransmission makes for a 
very interesting field of study, as mutations which confer functional changes in these channels 
may have dramatic, sometimes lethal (Rosati et al., 2011), consequences.  
 
Voltage-gated calcium channels (VGCCs) 
The action potential is the fundamental unit of communication in the nervous system. To 
make this mechanism of communication function seamlessly, VGCCs are integrated in the 
plasma membrane and are able to detect depolarizing changes in membrane potential. They are 
responsible for mediating the 20,000-fold gradient of calcium concentration in response to 
membrane depolarization (Clapham, 2007). Directly after an action potential fires, calcium 
rushes into the cell through VGCCs and facilitates the release of neurotransmitter from the 
presynaptic bouton.  
 Although there are five different types of VGCCs, there are a total of ten different 
proteins in the umbrella of the VGCC family – each with slightly different electrophysiological 
properties. To better understand the differences between individual channels, it is important to 
first address the structural composition that makes up the framework of a VGCC protein. 
Depending on the particular VGCC, the protein is composed of 4 or 5 subunits: α1, α2δ 
(α2 and δ), β, and γ (Bekircan-Kurt et al., 2015). The pore-forming subunit, also called the 
principal channel protein α1, is the defining feature of VGCCs in the current nomenclature. 
Specifically, there are ten different genes known to encode unique variations in the α1 subunit 
(Catterall, 2011) – and thus there are ten different kinds of VGCCs. Each of these ten variations 
in the α1 subunit varies in current properties and pharmacology (Catterall, 2011). The α1 subunit 
is 190 kDa in size and 2000 amino acid residues long (Tanabe et al., 1987), and this whole 
structure constitutes the ion channel pore which mediates Ca2+ flux. More than this, the pore-
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forming subunit also contains voltage-sensitive domains to detect shifts in membrane potential. 
After sensing a depolarizing voltage change large enough to induce VGCC opening, it 
selectively allows Ca2+ to pass through due to its selectivity filter and activation gate. Other 
domains exist within the α1 subunit which are responsible for driving protein-protein interactions 
or are the sites of modulatory activity. Due to the many qualities exhibited by the α1 subunit, it is 
interesting to note that expression of an α1 subunit alone in a heterologous cell is sufficient to 
recapitulate a functional ion channel – though with altered physiological properties from 
normally-functioning VGCCs (Campiglio and Flucher, 2015). This principal channel protein 
consists of four homologous repeats of six transmembrane domains, and is the central component 
of a VGCC which attaches to the other subunits of the protein complex (Catterall, 2011). 
While the α1 subunit is the defining characteristic of a VGCC, the other 4 auxiliary 
subunits must be taken into consideration. The calcium channel β subunit is the cytoplasmic 
protein in the VGCC complex, and has been shown to be involved with regulating voltage 
sensitivity and activation/inactivation kinetics of VGCCs (Neely et al., 1993; Josephson and 
Varadi, 1996). The α2δ auxiliary subunit is made of a disulfide-bridged dimer of the α2 and δ 
protein subunits (Takahashi et al., 1987). This subunit makes up the extracellular domain of the 
ion channel, and has a main function of increasing Ca2+ current (though also implicated in 
biophysical protein modifications) (Davies et al., 2006). Both the β and α2δ auxiliary subunits 
play an important part in ensuring proper channel folding and overall protein trafficking 
(Dolphin, 2016). Lastly, the γ1 subunit is an integral membrane protein found only in VGCCs in 
skeletal muscles (Dolphin, 2016). 
As previously stated, the ten different VGCCs are characterized by the specific pore-
forming (α1) subunit integrated into the protein complex. The calcium current of a given VGCC 
recorded at voltage of activation, as well as inactivation kinetics and pharmacological properties, 
were used to split the ten VGCCs into five types: L, P/Q, N, R, and T. The letters designated to 
each VGCC signifies an attribute of the observed calcium current for that channel: “L-type” 
refers to large calcium currents; “P/Q-type” refers to the discovery of calcium currents in 
Purkinje neurons (Llinás et al., 1989); “N-type” refers to a calcium current somewhere in 
between L- and T-type currents; “R-type” refers to the apparent resistance these channels had to 
pharmacological blockers of L-, P/Q-, and N-type calcium currents (Randall and Tsien, 1995); 
and “T-type” refers to transient calcium currents. In conjunction with the calcium current 
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classifier, the specific α1 subunit is also appended to the end of the indicated VGCC gene name 
(e.g. L-type VGCCs CACNA1C and CACNA1D have an α1C and α1D pore-forming subunit, 
respectively). Due to the somewhat convoluted nature of this nomenclature, a secondary 
mechanism of naming has been adopted by the field – though the original naming system also 
remains in use. In this new classification system, the protein is identified with “Ca” to symbolize 
its permeability to the Ca2+ ion, and a “V” is used in the subscript (CaV) to indicate that these ion 
channels are voltage gated. This designation is then followed by a numerical representation of 
the α1 subunit based on homological amino acid sequence (CaV1, CaV2, and CaV3) to indicate the 
family. Lastly, the order in which the ion channel of each family was discovered is appended to 
the numerical family representation (e.g. CaV1.1, CaV1.2, CaV1.3, and CaV1.4) (Ertel et al., 
2000).  
Voltage-gated calcium channels are located throughout the entire body and are well-
known by many for their role in neurotransmitter release from presynaptic neuron terminals in 
response to depolarizing membrane potential changes. However, in referring to these 
physiological properties, it is important to clarify that not all VGCCs are localized to presynaptic 
boutons and participate in neurotransmitter release. In fact, the CaV2 family are the VGCCs most 
associated with this aspect of neurotransmission – with the CaV3 family also being involved in 
presynaptic neurotransmitter release in some synapses (Cao and Tsien, 2010; Carbone et al., 
2014). The L-type VGCCs (LVGCCs) differ from their P/Q-, N-, R-, and T-type counterparts in 
that they do not play a role in the release of neurotransmitters from the presynaptic neuron (Biase 
et al., 2008; Jenkins et al., 2010). 
 
L-type voltage-gated calcium channels (LVGCCs) 
L-type voltage-gated calcium channels (LVGCCs) make up the CaV1 family of VGCCs, 
and are located throughout the body (Catterall, 2011). These four ion channels are expressed at 
different levels depending on the region of the body, but CaV1.2 and CaV1.3 are the only 
LVGCCs with high expression in the brain (Hetzenauer et al., 2006). On the other hand, CaV1.1 
and CaV1.4 are more abundantly expressed in skeletal muscle and the retina (Striessnig et al., 
2010). Typically LVGCCs are localized to the neuronal cell soma and dendrites in the 
mammalian nervous system (Hell et al., 1993), but a gap in the current literature exists regarding 
how these expression patterns may be affected in neuronal cultures. With the goal of elucidating 
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differences in gene expression in culture versus in vivo, a study in 2008 performed a series of 
comparative microarray experiments between retina explants in vitro and in vivo (Liu et al., 
2008). Remarkably, about 75% of the expressed genes had equivalent expression volume in vivo 
as in vitro – and only 1% of the expressed genes were reported to show a change threefold or 
greater (Liu et al., 2008). Though this study was conducted using mouse retina explants, the need 
for characterizing in vitro models of in vivo mechanisms is important to consider. If up to 6% of 
the gene population underwent even modest expression level changes in culture as compared to 
in vivo models (Liu et al., 2008), this means that there is potential for similar in vitro artifacts of 
gene expression in other contexts as well. Furthermore, the idea that gene expression can change 
due to variability in environmental conditions likely transcends retinal explant models; it may 
also be true that LVGCC models experience these changes as well.  
Importantly, recent in vitro findings suggest that LVGCCs have a similar somatodendritic 
Ca2+signal and molecular architecture as reported in brain neurons (Vierra et al., 2019). This 
study used both hippocampal neuron cultures and hippocampal slices, because the distribution of 
LVGCC expression and localization in hippocampi has been previously well-described (Hell et 
al., 1993). Although the discovery that LVGCCs have a similar molecular and physiological 
functionality in culture as in neurons of the intact brain, this study did not holistically address 
potential gene expression alterations using microarray comparisons like Liu et al. Instead, the 
researchers only performed immunostaining: a useful method of determining expression 
localization, but not the best way of determining expression levels. It should also be noted that 
these findings have yet to be recapitulated. The distinction between in vitro and in vivo 
experiments is important, because results of these studies may have different implications 
depending on the question being addressed. For example, when studying the differences in 
physiological properties of LVGCCs due to genetic mutations associated with an abnormal 
phenotype, it must be confirmed that the model being used is truly representative of the 
biological pathology and not just an artifact of the environmental conditions.  
 As was stated earlier, the expression of LVGCCs, namely CaV1.2 and CaV1.3, have been 
well characterized in the hippocampus. While CaV1.3 has a more general expression pattern, the 
expression of CaV1.2 is more restricted. In hippocampal CA1 there is high expression of CaV1.2 
in cell bodies of the pyramidal layer. Additionally, CaV1.2 is expressed in the cell bodies and 
dendrites of hippocampal CA2 and CA3, and the dendritic arborization of the dentate gyrus. In 
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contrast, CaV1.3 localizes to cell bodies and dendrites throughout the entire hippocampus (Hell et 
al., 1993). One other difference between CaV1.2 and CaV1.3 is their voltage sensitivity: CaV1.2 
channels begin opening at about -40 mV, while CaV1.3 channels begin opening at about -60 mV 
(Helton et al., 2005). 
 
Learning and memory: the role of LVGCCs 
The hippocampus is the memory subunit of the brain, and is a primary region of adult 
neurogenesis – a process with demonstrated importance for memory encoding (Altman, 1963; 
Toda et al., 2019). Given the high expression of LVGCCs in the hippocampus, and LVGCC’s 
involvement with adult neurogenesis (Temme et al., 2016), it is unsurprising that these ion 
channels have themselves been shown to mediate memory consolidation (McKinney and 
Murphy, 2006). 
 At present, the field commonly uses genetically manipulated mouse models to study the 
role of LVGCCs, specifically CaV1.2 and CaV1.3, in memory encoding. To accomplish this, 
mouse models have been generated with each aspect of LVGCC expression manipulation in the 
hippocampus: CaV1.2 over-expression (CaV1.2-HA), CaV1.2 deletion (CaV1.2-KO), CaV1.3 over-
expression (CaV1.3-HA), and CaV1.3 deletion (CaV1.3-KO) (Platzer et al., 2000; White et al., 
2008; Krueger et al., 2017). By only altering the expression of a LVGCC, we can further define 
the physiological function of a single ion channel. Thus, these genetic alterations are powerful 
tools and have allowed for significant advancements elucidating the role CaV1.2 and CaV1.3 play 
in important biological processes.  
 Importantly, modifications to postburst afterhyperpolarization (AHP) kinetics 
accompanies memory encoding (Moyer et al., 1996). An AHP consists of a hyperpolarization in 
the neuronal membrane potential immediately following a burst of spikes. The function of an 
AHP is to reduce firing by maintaining the membrane potential below spike threshold (Alger and 
Nicoll, 1980). Reducing the AHP results in a direct increase in neuronal excitability allowing for 
possible increases in firing rate from glutamatergic hippocampal neurons. The precise timing of 
this postsynaptic excitability window is thought to be significant for memory consolidation 
(Moyer et al., 1996), and as such is of high interest in the field of learning and memory research. 
In the scientific lexicon surrounding AHPs, it is common to subdivide them into three 
components: slow (s), medium (m), and fast (f) AHPs. The efflux of K+ ions at the end of an 
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action potential is the cause of each of these AHPs, with the principal difference between the 
three being the temporal scale of repolarization (as indicated by the terms “slow,” “medium,” 
and “fast”). The fAHP lasts about 1-5 ms and is dependent on both calcium concentration and 
voltage (Lancaster and Nicoll, 1987). The mAHP has a decay constant of about 100-200 ms, and 
the sAHP has a decay constant on the order of 1000-5000 ms (Storm, 1990). The fAHP operates 
through BK-type channels (Storm, 1987), but the channels responsible for the K+ current 
underscoring mAHPs and sAHPs remains unclear. The concentrations of calcium necessary for 
the K+ responsible for these AHPs is also unknown.   
A link exists between varying sAHP magnitude and memory consolidation during 
learning performance tasks. A reduced sAHP was observed in successfully trained mice in 
comparison to untrained mice performing the same learning task (Disterhoft et al., 1996). The 
dynamic of sAHP magnitude is intricate: too high and neurons will be overly inhibited, too low 
and neurons will be overly active. In fact, increased sAHPs, and thus longer refractory windows, 
are linked with decreased performance in learning tasks (Murphy et al., 2004, 2006). Likewise, 
sAHPs of smaller magnitude resulted in impaired memory performance (Perkowski and Murphy, 
2011). 
In 2006, McKinney and Murphy conducted an experiment using CaV1.3-KO mice to 
study neural mechanisms of memory. This was the first study that justifiably concluded that 
CaV1.3 mediates memory consolidation, as indicated by CaV1.3-KO mice displaying impaired 
contextual fear conditioning but normal freezing patterns when compared to wild-type 
littermates (McKinney and Murphy, 2006). Because decreased sAHPs could result in memory 
impairment (Perkowski and Murphy, 2011), and the deletion of CaV1.3 (but not CaV1.2) results 
in decreased sAHP amplitude (Gamelli et al., 2011), the findings of this 2006 study are robustly 
accepted in the field. Of note, the Murphy Lab group has also shown that CaV1.2 is involved 
with memory encoding – as conditional knockout (CaV1.2-KO) mice displayed impaired spatial 
memory performance in comparison to wild-type littermates (White et al., 2008).  
 Taken together, there is substantial evidence suggesting that a loss of function mutation 
in CaV1.2 or CaV1.3 results in impaired memory performance. However, the physiological role 
of calcium underpinning these abnormal phenotypes remains elusive. To fully comprehend the 
mechanisms of action by which these LVGCCs operate it is imperative that we design 
experiments that allow us to begin drawing conclusions about the calcium dynamics resulting 
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from altered LVGCC expression levels. Although learning and memory processes have been 
shown to be affected by LVGCC deletions, understanding the physiological implications of these 
calcium channels will open the door for research in a context even broader than that of the 
hippocampus. 
 
Neuropsychiatric disorders: mutations in LVGCCs 
L-type voltage-gated calcium channels mediate postsynaptic responses within 
pathophysiologically relevant neural pathways associated with numerous neurodevelopmental 
and psychiatric disorders (Deisseroth et al., 1998; Mermelstein et al., 2000). Of these pathways, 
both CaV1.2 and CaV1.3 are functionally important in the hippocampus, amygdala, and 
mesolimbic reward system (Rajadhyaksha and Kosofsky, 2005; McKinney and Murphy, 2006; 
Temme and Murphy, 2017): all of which are brain regions responsible for mediating behavior 
patterns. Given this, it is reasonable to consider the possibility that even slight deviations from 
the normal transcript may result in altered brain function. 
There exists a SNP near CACNA1C, the gene which encodes the α1C subunit of CaV1.2, 
which has been linked to significant risk for development of Timothy syndrome – a syndromic 
autism spectrum disorder caused by a gain-of-function missense mutation. In the time since the 
association of this gene with high risk for developing Timothy syndrome was published in 2004 
(Splawski et al., 2004), significant developments have been made in attempt to uncover how this 
mutation contributes to the autistic phenotype (Boczek et al., 2015). While this missense 
mutation has been shown to significantly reduce voltage-sensitivity of CaV1.2 (Splawski et al., 
2004), there is a need to understand the resulting effects on calcium dynamics. 
 In 2008, a different SNP located near CACNA1C was identified as one of the strongest 
susceptibility loci for bipolar disorder (Ferreira et al., 2008a). Subsequent studies have elucidated 
the role of the CACNA1C risk allele, showing its responsibility for upregulated expression levels 
of CaV1.2  (Bhat et al., 2012). While bipolar disorder is a psychiatric disorder specifically 
referenced in these GWA studies, other research has found alterations in the expression of 
CaV1.2 to yield behavior representative of schizophrenia (Bigos et al., 2010). 
More recently, in 2016, the association of a CACNA1D mutation with bipolar disorder has also 
been implicated (Ross et al., 2016). Alterations in this gene would directly affect CaV1.3 
function, as it is the gene which encodes the α1D pore-forming subunit of the LVGCC. 
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 The demonstrated importance of genetic mutations affecting the principal channel protein 
cannot be ignored. To clarify the contribution these genetic mutations may have on the 
aforementioned behavioral and physiological phenotypes, genetically manipulated mouse models 
may be used to study underlying calcium dynamics. Specifically, an over-expressed CaV1.2 
model would serve to recapitulate the gain-of-function mutation associated with neuropsychiatric 
disorders. Additionally, an over-expressed and knockout CaV1.3 model would be helpful to 
study, as it is not known if the effect of disorder-associated SNPs located near CACNA1D 
confers a gain- or loss-of-function mechanism of action. 
 
Specific Aims  
The goal of this study was two-fold. First, in vitro calcium imaging was utilized to further 
understand how calcium dynamics are affected due to alterations in Cacna1c or Cacna1d 
expression levels. These results provide novel insight into how gain- or loss-of-function 
mutations in LVGCCs contribute to pathophysiological phenotypes (McKinney and Murphy, 
2006; Bhat et al., 2012). A second initiative of this study was to localize expression of CaV1.2 
and CaV1.3 in culture, as these in vitro expression patterns have not been well-described in 
current literature. Further defining where these LVGCCs are localized in vitro is helpful for 
narrowing our focus to specific cell regions, yielding higher spatial resolution for future calcium 
imaging experiments. Together, these studies work cohesively to elucidate the location and the 
mechanism by which genetic mutations responsible for modified LVGCC expression levels 
contribute to altered calcium dynamics. 
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Materials and Methods 
Mice 
Except where noted, all genetically engineered mice were bred in house and wild-type 
littermates were used as controls. All mice used in this study were generated or maintained (>20 
generations) on a C57B/L6Tac genetic background. Experiments included four different mouse 
models: mice that over-expressed CaV1.2 or CaV1.3, and mouse models which completely lacked 
expression of CaV1.2 or CaV1.3 (so called “knock out” [KO] mice). 
In both over-expression models, full length transcripts for the pore-forming subunit were 
modified to contain a hemagglutinin (HA) epitope tag in an extracellular loop and are referred to 
here after as the CaV1.2-HA and CaV1.3-HA lines. The over-expression of CaV1.2 was driven by 
the ubiquitous CAG (CMV enhancer, chicken beta-actin) promoter whose activity is regulated 
by a lox-P flanked stop codon cassette located 5’ to the ATG sequence of the transgene. For the 
current study, the CaV1.2-HA mice were crossed with mice in which expression of Cre 
Recombinase was driven by the Synapsin 1 promoter (“Synapsin-Cre” mice; Zhu et al., 2001) 
which restricted CaV1.2-HA expression to neurons. Expression in the CaV1.3-HA line was driven 
by the alpha calcium calmodulin kinase II promoter and is thus restricted to glutamatergic 
neurons in the forebrain (Krueger et al., 2017). 
Mice lacking CaV1.2 (referred to here after as CaV1.2-KO mice) were engineered such 
that CaV1.2 could be deleted in a cell-type specific manner because the global CaV1.2-KO mice 
exhibit embryonic lethality (presumably due to expression on the heart). To achieve conditional 
deletion, mice in which the second exon of Cacna1c (the gene encoding CaV1.2) was flanked by 
lox-P sites (White et al., 2008) were crossed the Synapsin-Cre mice, resulting in apportion of the 
offspring which were CaV1.2f/-:Cre+. These mice were intercrossed to obtain pure wild-type mice 
(CaV1.2f/f:Cre-) and true CaV1.2-KO mice (CaV1.2-/-:Cre+). 
Mice lacking CaV1.3 (referred to here after as CaV1.3-KO mice) were made by 
homologous recombination such that exon 2 of Cacna1d (the gene encoding CaV1.3) was 
replaced by a neomycin-resistant cassette which results in a missense frame shift effectively 
producing a heterozygous null mutation. Heterozygous null CaV1.3 mice were intercrossed to 
obtain CaV1.3-KO mice and wild-type littermates. 
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All mice were fed ad libitum and kept on a 14:10-h light:dark schedule. All procedures 
involving mice were approved by the University of Michigan Institutional Animal Care and Use 
Committee (approval number for the protocol: PRO00008648; principal investigator: Geoffrey 
Murphy, PhD) and performed according to the National Institute of Health guidelines for animal 
care.  
 
Hippocampal neuron cultures 
To prepare cell cultures, hippocampi were harvested from mouse pups at postnatal day 1-
2 following genotyping. Meninges were removed to facilitate tissue extraction. This was done in 
HEPES buffered saline solution (HBSS) – a physiological saline containing the following (in 
mM): NaCl 136, KCl 2.5, HEPES 10, glucose 10, CaCl2 2, and MgCl2 1.3. The HBSS was then 
adjusted to pH 7.4. The hippocampi were isolated and harvested, then placed in HBSS on ice. An 
18 mm glass coverslip was placed in a 35 mL dish. A poly-D-lysine agent from the freezer was 
added to the coverslip to supply negative charge, allowing negatively-charged lipids from cell 
membranes to adhere well. In 2 × 10 mL HBSS vials with 10 mM hepes, the following 2 
ingredients were added: L-cysteine (3.2 mg) and L-papain (240 μL). L-cysteine activated L-
papain to enhance its enzymatic activity, so that it was able to break down protein bonds between 
synapses. Vials were sterilized with ethanol and placed in a 37°C water bath to facilitate mixture.  
HBSS solution was removed from hippocampal slice vials, and the L-papain solution was 
introduced through a filter into the vials. These vials were placed back in the water bath at 37°C 
for 15 min.  The tubes were inverted every 2.5 min to ensure that the solution was equally 
distributed. After 15 min, the hippocampus was washed 3 times with cold HBSS, then the vial 
was placed on ice. All HBSS solution was removed from the hippocampal vials and placed in 
new vials; care was taken to not remove the hippocampal slices. The new vials were centrifuged 
for 5 min at 0.6 relative centrifugal force (RCF) to allow cells to aggregate into a pellet at the 
bottom of the tube. This allowed us to get rid of HBSS solution and replace with NbActiv4 
(BrainBits, Nb4) for culture. Nb4 is the salt solution the neurons are cultured in: it has factors 
that mimic developmental physiological conditions (with Ca2+, Mg2+, cholesterol, B27, glutamic 
acid, and estrogen with added glucose). After centrifuge, HBSS solution was removed, and the 
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pellets were placed in 50 μl of NB4 for 1 hour. After 1 hour, 2 ml of Nb4 were placed on plates, 
and moved to a humidified incubator at 95:5 (O2: CO2) and 37ºC.  
 
Antibodies 
The antibodies used included the following: anti-HA (Roche; rat, #11867423001, 
immunocytochemistry [ICC] 1:500), anti-MAP2 (abcam; chicken, #ab5392, ICC 1:5000), goat 
anti-rat secondary (abcam; #ab150167, ICC 1:500, Alexa Fluor 647), and goat anti-chicken 
secondary (abcam; #ab150170, 1:500, Alexa Fluor 555). Immunocytochemical mounts were 
treated with ProLong Diamond Antifade containing 4’6-diamidino-2-phenylindole (DAPI; 
Invitrogen, # P36935). 
 
Immunolabeling of cells 
Neuronal cultures were fixed and processed for immunocytochemistry as described by 
Glynn and McAllister (2006), with the exception that bovine serum was substituted for goat 
serum. Briefly, primary antibodies were added at given dilutions in 3% goat serum for 1 h 
followed by washes (3% goat serum in PBS, 5	× 5 min), and secondary antibodies (diluted in 
PBS) were added for 45 min followed by 5	× 5 min washes in PBS. Confocal images were 
acquired using an Olympus FV1000 microscope equipped with a photomultiplier tube and a 40× 
NA objective lens. To obtain these images, we used Olympus Fluoview software and lasers with 
the following wavelengths (in nm): 405, 561, 633. This excitation resulted in the following 
respective photon emission wavelengths (in nm): 421, 565, 647. 
Confocal fluorescence images were analyzed for colocalization using the JACoP plugin 
for Fiji (Bolte and Cordelières, 2006). The Pearson R correlation coefficient was created using 
spatially matched pixels for two images of different fluorescent intensities (Costes et al., 2004). 
Automatic thresholding and a Costes randomization of N = 20 was applied. Images presented in 
this study were subjected to rolling ball background subtraction and Gaussian Blur of Sigma 
(radius) = 0.5.  
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In vitro calcium imaging 
In vitro calcium imaging was employed to functionally assay voltage-gated calcium 
channel activity of genetically manipulated mouse models. Calcium imaging was used as a 
surrogate for traditional electrophysiology to observe differences in patterns of action potential 
firing, because this technique allows observation of multiple neurons simultaneously, yielding a 
higher throughput than electrophysiological studies. Additionally, in vitro calcium imaging 
allows for a better temporal analysis than electrophysiology when distinguishing between 
individual cell bodies and dendrites. 
Imaging was conducted after 14–21 days in vitro (DIV), with the cells being fed every 3-
4 days. A 3-day window without feeding was maintained between the most recent change in 
media and the first day of imaging. Spontaneous and evoked Ca2+ transients of neurons cultured 
under control conditions were compared. Cell cultures were loaded with calcium dye Fluo-5 AM 
(Invitrogen) in a 1:1000 HBSS dilution and incubated for 10 min. The dye solution was then 
aspirated, and the cell cultures were washed twice for 1 min with HBSS before transferring the 
cover slip to the microscope stage for recording. Once the mounted on the stage, 100 µL HBSS 
was added on top of the coverslip.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
For each dish, imaging was conducted under two conditions: spontaneous activity and 20 
Hz stimulation. For recording evoked stimulation, there was an event delay of 40 seconds 
followed by a 50-100 V stimulation. To enumerate, the 20 Hz stimulation occurred for 2 
seconds, 40 seconds into the recording time, totaling in a 40-pulse stimulation. Each recording 
lasted for 70-90 seconds to ensure calcium activity returned to baseline post-stimulation at 40 
seconds. To capture frames as fast as possible, roughly 130-160 millisecond intervals were used 
and roughly 530-564 cycles were obtained. 
To isolate responses to field stimulation, we blocked synaptic transmission with 
glutamate receptor antagonists: 10-25 μM CNQX (Tocris) and 50 μM L-AP5 (Tocris) in 100 µL 
HBSS. This 100 µL blocker solution was added to the 100 µL HBSS already present in the 
recording chamber. Blockers were added after recording spontaneous activity, and 2-5 min 
incubation time was allowed before recording activity from evoked stimulation. 
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The Olympus - IX83 microscope was used together with the Olympus cellSens software 
to obtain images. Images were acquired using a 20× NA objective lens. Illumination was 
achieved using a Lumencor SpectraX high intensity LED light engine and images were captured 
with a Prime 95B QE Backside illuminated high speed CMOS camera (Photometrics). Images 
were recorded at a capture rate of 0.16 Hz for 90 s, yielding a total of 563 frames per recording. 
The GFP fluorescent laser (excitation 488 nm) was used to excite photons (emission 509 nm) 
from the Fluo-5 AM dye loaded into the neuronal cultures. A field of view (FOV) for recording 
was selected primarily based on density of neurons and glia, along with intensity of calcium 
indicator dye at baseline. High-intensity neurons were avoided when searching for a FOV, as this 
indicated potential calcium dye overloading and/or cell death – neither of which is ideal for 
monitoring calcium activity in this study (Fig. 1). 
Calcium imaging data was analyzed off line using FIJI (Bolte and Cordelières, 2006). 
Image stacks were corrected for photobleaching with an exponential fit. A threshold was then 
applied to create a binary mask image using the DiffImage1C plugin for evoked responses or the 
dFoverFmovie plugin for spontaneous activity. Next, 10-150 regions of interest (ROIs) were 
generated using the particle analysis plugin. Both cell bodies and dendrites were considered 
when selecting ROIs for this study unless otherwise specified. Using the Time Series Analyzer 
V3 plugin (Balaji, 2014), ROIs were individually analyzed in each frame for changes in 
fluorescence as indicated by the Fluo-5 AM calcium dye intensity. Graphpad Prism 8 was then 
used to combine data for visualization and statistical comparison.  
 
Statistical analysis 
Graphpad Prism 8 was used to combine data for visualization and statistical comparison. 
Maximum amplitudes were compared between genotype groups using an unpaired two-tailed t-
test. An unpaired two-tailed t-test was also used to compare Pearson’s correlation coefficient 
(PCC) data when looking for colocalization between MAP2 and HA in immunocytochemistry. 
These tests were appropriate, because the data were normally distributed and satisfied parametric 
assumptions. A threshold of 𝛼=0.05 was used to determine significance. Sample means and 
variances are presented as mean ± standard error of the mean (SEM) throughout this study.  
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Figure 1. Representative fields of view (FOVs) during calcium imaging. All images in 
this figure were taken at 20× magnification. A, there is relatively high neuron density in 
this FOV, with a low amount of glia present. The white arrow at left indicates a high-
intensity neuron, likely due to calcium dye overloading and/or cell death. Neurons that 
look like this were avoided if possible. This image was subjected to rolling ball 
background subtraction and Gaussian Blur of Sigma (radius) = 0.5. B, the FOV at left 
represents baseline fluorescence for a WT neuronal culture, while the right image 
represents the same FOV in response to a 20 Hz (40-pulse) stimulation at 100 V. These 
images were corrected for photobleaching using an exponential fit model, with 
otherwise no image processing. 
 
Figure 1 
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Results 
Initial insight into altered CaV1.2 and CaV1.3 calcium dynamics 
Previous studies have demonstrated the importance of altered CaV1.2 and CaV1.3 
expression levels in memory consolidation and neuropsychiatric disorders (McKinney and 
Murphy, 2006; Bhat et al., 2012). To expand upon these findings, we sought to characterize the 
calcium dynamics resulting from genetic manipulations of Cacna1c and Cacna1d. To 
accomplish this, in vitro calcium imaging of mouse hippocampal neuron cultures was employed. 
Glutamatergic ion channel blockers CNQX and AP5 were applied to eliminate activity due to 
synaptic activation, and a 20 Hz stimulus of 50 V was introduced 40 seconds into the recording. 
Calcium activity within neuronal cultures was measured as a function of fluorescent intensity 
over time, then compared between a genetically manipulated mouse model and a wild-type 
littermate.  
There appeared to be a decrease in calcium transients upon over-expression of CaV1.3 
(CaV1.3-HA), and an increase in activity due to CaV1.3 deletion (CaV1.3-KO; Fig. 2A). This is 
represented by a comparison of average maximum amplitudes of neurons observed within these 
traces (CaV1.3-WT=0.2997, CaV1.3-HA=0.1589; CaV1.3-WT=0.0808, CaV1.3-KO=0.2430). 
Likewise, CaV1.2-KO neuron cultures appeared to yield increased levels of calcium activity 
compared to cultures prepared from their wild-type littermates (CaV1.2-WT=0.1653, CaV1.2-
KO=0.1813; Fig. 2B). At the time this experiment was conducted, the CaV1.2-HA transgenic line 
had not yet been generated for study and thus are not shown in these graphs. It should be noted 
that the sample size (N) in this experiment is represented as individual neuronal cell bodies. This 
is important to address because subsequent experiments presented in this study define N as 
including both cell bodies and dendrites. 
We reasonably expected that over-expression of LVGCCs would lead to an increase in 
the observed level of calcium activity, and analogously that deletion of these channels would 
yield a reduction. Although no statistical comparisons were performed, these data provided the 
first glimpse into a potentially counterintuitive mechanism of action for these LVGCCs. In 
addition to the seemingly reciprocal pattern of these findings, there were inconsistencies in the 
level of calcium activity observed in the wild-type control neuron cultures (CaV1.3-WT=0.2997, 
0.0808; CaV1.2-WT=0.1653). To uncover any truth behind these counterintuitive findings and 
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account for potential variability between cultures, we next decided to increase our sample size 
and consider the effects of over-expressing CaV1.2 on calcium activity in neuron cultures. 
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Figure 2 
Figure 2. Time traces from a preliminary study conducted in 2017. Time traces 
displayed here represent average cell body response of a given genotype to a 20 Hz (40-
pulse) 100 V stimulus introduced at an event delay of 40 s. In the graphs shown, the 
3000 ms surrounding the cellular response to the 20 Hz stimulus is shown. Calcium 
activity is measured as (ΔF/F0)-1. A, time traces of CaV1.3-HA neuronal cultures (red 
dashed) and CaV1.3-KO neuronal cultures (green dashed) compared to their wild-type 
(WT) littermates (dark red and dark green, respectively). Data include the following 
sample sizes: CaV1.3-HA, N=22, CaV1.3-WT (CaV1.3-HA littermates), N=10, CaV1.3-
KO, N=26, CaV1.3-WT (CaV1.3-KO littermates), N=8. B, time traces of CaV1.2-KO 
neuronal cultures (blue) compared to their WT littermates (black). Data include sample 
sizes: CaV1.2-KO, N=24, CaV1.2-WT (CaV1.2-KO littermates), n=17. 
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Reciprocal pattern of calcium transients due to manipulated CaV1.3 expression 
Given the inverse relationship of calcium activity observed in our preliminary experiment 
(Fig. 2), we next asked if increasing the sample size of CaV1.3-HA, CaV1.3-KO, and CaV1.3-WT 
would yield significance. As mentioned previously, CaV1.3 channels are expressed in both cell 
bodies and dendrites of hippocampal neurons of the intact brain (Hell et al., 1993). Thus, we 
decided to consider cell bodies and dendrites together in our analysis of calcium transients (as 
opposed to only considering individual neuronal cell bodies as ROIs – the method of Figure 2 
experiments). 
 After imaging in vitro calcium activity of CaV1.3-HA neuronal cultures, representative 
traces of calcium activity were plotted as a function of fluorescent intensity over time (Fig. 3A). 
Upon introduction of a 20 Hz stimulus 40 seconds into recording, calcium transients elicited 
peak fluorescent amplitude in each time trace. Off-line analysis revealed no significant 
difference in average maximum amplitude between mutants and CaV1.3-WT (p>0.05; Fig. 3B). 
This lack of significance is likely due to the consideration of entire fields of view as individual 
samples. Also consistent with our 2017 preliminary experiment, CaV1.3-KO neuronal cultures 
appeared to exhibit a decrease in maximum amplitude when compared to wild-type littermates 
(Fig. 3D). However, statistical analysis conferred no significant findings in this comparison 
(p>0.05). There was an error in maintaining a constant image acquisition rate between CaV1.3-
HA and CaV1.3-KO experiments, so CaV1.3-KO time traces are plotted as a function of frames 
rather than time (Fig. 3C). 
Due to the consistent pattern observed between this experiment and the experiment 
conducted in 2017 (Fig 2A), we expect that increasing the sample size even further in future 
studies – thus increasing statistical power – would reveal a significant decrease in maximum 
calcium activity amplitude of CaV1.3-HA compared to wild-type littermates. Similarly, we 
would expect increasing sample size in future studies to demonstrate a significant increase in 
maximum amplitude for CaV1.3-KO neuronal cultures. 
During the period of CaV1.3-KO data collection, voltage was generated by current output 
across a resistor to achieve the 20 Hz stimulus. While this voltage was estimated to be around 50 
V in magnitude, all other experiments (including Fig. 3A and Fig. 4A) were performed at a 
precisely measured 100 V. This adjustment was made to accommodate the observed lack of 
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response from neuronal cultures (wild-type) to maximum voltage output using the current 
generator setup in recordings subsequent to the CaV1.3-KO experiment. The current-resistor 
method of achieving voltage output was replaced by a battery, which directly outputs voltage of 
a set value. To ensure the output was consistent with the value set by the battery, we attached an 
oscilloscope to confirm that the measured voltage at the end of the recording chamber wires 
matched the indicated battery output. We then performed a voltage titration on spare wild-type 
neuronal cultures and discovered 100 V to be the optimal voltage for future recordings. This was 
determined based on the observably similar fluorescent response compared to previous 
recordings performed with the current-resistor setup. In doing so, we discovered 100 V to be the 
optimal voltage for future recordings. 
 The representative time traces of calcium activity depict variability in the wild-type 
response to the 20 Hz stimulation (Fig. 3A and Fig. 3C). While this may be in part due to the 
above-reported inconsistencies in recording conditions, it is not uncommon to observe slight 
variability in calcium response in vitro (see Vierra et al., 2019).  
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Figure 3. Counterintuitive calcium transients as a result of altered CaV1.3 
expression levels. Individual time traces were plotted as the average fluorescence 
change ((ΔF/F0)-1) for a representative neuronal culture of a given genotype over time. 
The blue dashed line indicates the 20 Hz (40-pulse) 100 V stimulus introduced at time 
t=40000 ms. A, time trace of a CaV1.3-HA neuronal culture (dark red) compared to WT 
littermate (black). Data include the following sample sizes (ROIs for an individual 
culture): CaV1.3-HA, N=61, CaV1.3-WT (CaV1.3-HA littermates), N=113.  
(figure 3 legend continued on next page) 
 
Figure 3 
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B, comparison of maximum amplitudes for CaV1.3-WT (N=4 neuronal cultures; mean = 
0.2652) vs. CaV1.3-HA (N=10; mean=0.1569); p=0.0960 (two-tailed t-test). C, time 
traces of CaV1.3-KO neuronal cultures (green) compared to their WT littermates 
(black). Note the change in (ΔF/F0)-1 scaling on the y-axis. The x-axis represents 
frames imaged throughout the recording rather than time, because the acquisition 
interval was not recorded for this portion of the experiment. Data here include sample 
sizes (ROIs for an individual culture): CaV1.3-KO, N=125, CaV1.3-WT (CaV1.3-KO 
littermates), N=120. D, comparison of maximum amplitudes for CaV1.3-WT (N=2 
neuronal cultures; mean = 0.3748) vs. CaV1.3-KO (N=2; mean=0.5140); p=0.0960 
(two-tailed t-test). Data are represented as mean ± SEM. 
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Reciprocal pattern of calcium transients due to manipulated CaV1.2 expression 
We next addressed the effect of genetic manipulations of Cacna1c on calcium dynamics. 
Only effects of CaV1.2 over-expression were reported, as CaV1.2-KO mice were allotted to 
different studies. Upregulation of CaV1.2 yielded no significant difference in maximum 
amplitude of calcium response (p>0.05; Fig. 4B). However, the CaV1.2-HA trace presented is 
representative of all samples recorded, and our sample size was limited by the breeding pattern 
of CaV1.2-HA mice (Fig. 4A; N=3 neuronal cultures). Furthermore, we expect that increasing 
the sample size of this experiment will exacerbate the trend of decreased maximum amplitude in 
CaV1.2-HA. 
The calcium activity pattern presented in this experiment was not unexpected, given the 
striking resemblance of CaV1.2-HA time traces to previously observed effects of CaV1.3 over-
expression (Fig. 3A and Fig. 3B). Additionally, both the CaV1.2-HA and CaV1.3-HA time traces 
display calcium responses to a precisely measured 100 V stimulus.  
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Figure 4. Counterintuitive calcium transients as a result of altered CaV1.2 
expression levels. Individual time traces were plotted as the average fluorescence 
change ((ΔF/F0)-1) for a representative neuronal culture of a given genotype over time. 
The blue dashed line indicates the 20 Hz (40-pulse) stimulus introduced at time 
t=40000 ms. A, time trace of a CaV1.2-HA neuronal culture (blue) compared to WT 
littermate (black). Data include the following sample sizes (ROIs for an individual 
culture): CaV1.2-HA, N=58, CaV1.2-WT (CaV1.2-HA littermates), N=56. B, 
comparison of maximum amplitudes for CaV1.2-WT (N=3 neuronal cultures; mean = 
0.2974) vs. CaV1.2-HA (N=3; mean=0.1696); p=0.1567 (two-tailed t-test). Data are 
represented as mean ± SEM. 
 
Figure 4 
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CaV1.2 and CaV1.3 channels localize in dendrites of hippocampal neuron cultures 
To better understand how manipulating expression levels of LVGCCs in mouse neuronal 
cultures affects calcium dynamics, we used immunocytochemistry (ICC) to spatially map CaV1.2 
and CaV1.3 channels. It has been established that LVGCCs are unique from other VGCCs in that 
they are most abundantly expressed postsynaptically in neurons of the intact brain (Hell et al., 
1993). However, the expression patterns of LVGCCs in neuronal cultures have been less well-
defined. This motivated our investigation, as understanding the localization of CaV1.2 and 
CaV1.3 in cultured neurons would provide higher spatial resolution for future calcium imaging 
experiments. 
 At the time our study was conducted, there were no antibodies specific enough to 
distinguish between CaV1.2 and CaV1.3 channels. As such, we used an antibody against the HA 
epitope of the over-expressed LVGCC transgene. Because HA is used as an over-expression 
marker in both the CaV1.2-HA and CaV1.3-HA models, we were only able to study one LVGCC 
at a time. In conjunction with HA-staining, an antibody against MAP2 was utilized as a dendritic 
marker. Finally, after double-staining for HA and MAP2 expression, we counter-stained using 
the nuclear marker DAPI. 
 Representative images reflect the localization of CaV1.2 and CaV1.3 to dendrites (Fig. 5B 
and Fig. 5D). Colocalization analysis of HA and MAP2 was conducted to generate Pearson’s 
correlation coefficient (PCC). The PCC was calculated using a linear equation to describe the 
relationship of fluorescent intensity between HA and MAP2 channels (Costes et al., 2004). For 
this analysis, a p-value above 95% represented significant colocalization of HA with MAP2. In 
every case, CaV1.3-HA and CaV1.2-HA images were found to significantly colocalize with 
MAP2 (p>95%). In all but one case, CaV1.2-WT and CaV1.3-WT control images failed to 
demonstrate colocalization between HA and MAP2 (p<95%; Fig. 5A and Fig. 5C). 
While CaV1.2-HA and CaV1.3-HA colocalized with MAP2, the PCCs for each wild-type 
control also demonstrated positive correlation. Thus, when statistical comparison was performed 
between PCCs of over-expressers and wild-type neuron cultures, no significant difference was 
discovered (p>0.05; Fig. 5E and Fig. 5F). There should have been no observable fluorescence in 
the HA channel of wild-type images, as only the over-expressed LVGCC transgenes contain the 
HA epitope. However, we recognize that there were no antibody controls presented in this study; 
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this was a preliminary experiment, and as such calcium imaging experiments demanded priority 
of available neuronal cultures.  
A source of error is rooted in the the magnification of these images, which appears to be 
inconsistent. Though the scale-bars were all generated using metadata stored by the confocal 
microscope, the resolution of these images appear to be variable. 
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(figure legend on next page) 
Figure 5 
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Figure 5. Immunocytochemical labeling of MAP2 and HA. The MAP2 protein is 
used as a dendritic marker, while HA immunolabeling shows expression of the 
respective LVGCC. The merged images in the rightmost column allow for visualization 
of colocalization between MAP2 and HA. All images were taken at 20× magnification. 
A, CaV1.3 WT immunolabeling. B, CaV1.3-HA immunolabeling. C, CaV1.2-WT 
immunolabeling. D, CaV1.2-HA immunolabeling. E, Pearson’s correlation coefficient 
(PCC) values of HA and MAP2 immunolabeling in CaV1.2-WT (N=2) vs. CaV1.2-HA 
(N=1). Each point represents a single neuronal culture (p=0.2776; two-tailed t-test). F, 
PCC values of HA and MAP2 immunolabeling in CaV1.3-WT (N=3) vs. CaV1.3-HA 
(N=6). Each point represents a single neuronal culture (p=0.4289; two-tailed t-test). 
Data are represented as mean ± SEM. All images presented in this figure were 
subjected to rolling ball background subtraction and applied a Gaussian Blur of Sigma 
(radius) = 0.5 after colocalization analysis was performed. 
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Discussion 
 In this study, we presented data that work to elucidate the effect of LVGCC genetic 
manipulations on underlying molecular dynamics. Mutations in CaV1.2 and CaV1.3 have been 
identified as risk alleles for development of neuropsychiatric disorders (Ferreira et al., 2008b; 
Ross et al., 2016b). Additionally, mutations affecting the Cacna1c (CaV1.2) and Cacna1d 
(CaV1.3) genes disrupt spatial memory and impair memory consolidation, respectively 
(McKinney and Murphy, 2006; White et al., 2008). To our knowledge, this is the first set of 
experiments reporting the effects these genetic manipulations may have on resulting calcium 
physiology. 
 Calcium is involved in many biochemical mechanisms throughout the body; thus, even 
slight deviations in calcium signaling may be detrimental not only to brain function but also 
overall health. While we have reported no significant differences in the maximum amplitude of 
calcium transients among the different transgenic LVGCC models in this study, further 
investigation is warranted. The sample sizes of each experiment were lower than desired, 
preventing us from making any robust claims. Nonetheless, data consistently pointed towards a 
reciprocal relationship between expression level and maximum calcium – a measure of overall 
calcium activity. We believe that increasing the number of neuronal cultures for each genotype 
would strengthen this trend, potentially enough to yield significance.  
As presented in this study, it is best practice to match experimental mice with littermates 
to eliminate potential confounds of environmental influences. However, it is interesting to note 
that when all wild-type data (CaV1.3-WT and CaV1.2-WT combined) were compared to CaV1.3-
HA, a two-tailed t-test revealed significant results (p=0.0367). Though controlling for 
environmental conditions should not be disregarded, this further suggests that there is at least 
some merit to the counterintuitive calcium activity patterns reported in this study. Consideration 
must also be given to our definition of individual samples: in the most recent experiments 
reported (Fig. 3 and Fig. 4), we classified FOVs as samples for amplitude comparison. This 
differs from our earlier experiment (Fig. 2), which defined an individual neuronal cell body as a 
sample. No statistical analyses were performed on the earlier calcium imaging trial but re-
defining our sample size in this way would be a reasonable way to increase the power of our 
more recent findings. Additionally, this method of reevaluation would allow use to compare data 
between earlier and more recent trials. 
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The findings we have reported regarding calcium dynamics only include comparisons of 
maximum amplitude between neuronal cultures of different genetic backgrounds. Parameters not 
accounted for in this study include frequency of spontaneous activity and width/area under the 
curve of calcium transient time traces. Additionally, a longer train of lower-frequency stimulus 
(such as 0.2 Hz for a 20 second epoch) should be analyzed to more closely mimic physiological 
conditions in the hippocampus (Dudek and Bear, 1992). Further analysis of these factors is 
required to more holistically evaluate distortions in LVGCC kinetics. 
The variability in the wild-type time traces during calcium imaging experiments remains 
elusive. There appears to be an intrinsic variability in evoked calcium responses among wild-
type cells, likely due to environmental artifacts of neuronal cultures. The fluctuating level of 
control group responses in this study limits us from drawing any translational implications from 
genetic manipulation of Cacna1c or Cacna1d. Other calcium imaging studies focused on 
LVGCCs have reported maximum amplitudes of wild-type hippocampal neurons between 0.2 – 
1.3 (ΔF/F0) within the same culture (Vierra et al., 2019). Thus, our observation seems to be 
normative in the field, and we must continue calcium imaging experiments to delineate a 
standard response.  
Despite variability observed among neuronal cultures, the inverse trend of expression 
level with calcium activity was consistent and merits continued investigation. A subsequent 
study to confirm or refute our findings in neuronal cultures might include performing calcium 
imaging experiments on hippocampal slices. Because the expression pattern of LVGCCs are 
well-characterized in hippocampal circuitry (Hell et al., 1993), we could perform a similar 
experiment with the substitution of hippocampal slices in replacement of hippocampal neuronal 
cultures. Recording calcium activity patterns in the intact hippocampus would allow us to 
explore cell-type specific differences in LVGCC calcium dynamics – a mechanism of high 
interest in the field of learning and memory. This would be a more representative model of 
potentially affected calcium dynamics but would considerably compromise the spatial resolution 
achievable using a neuronal culture model. 
The use of a biologically based fluorescent indicator to measure calcium activity is of 
potential interest for future calcium imaging experiments. Genetically encoded calcium 
indicators (GECIs), such as GCaMP6f – a commonly used calmodulin (CaM)-dependent 
fluorescent marker, are commonly used for their high specificity in tracking hippocampal 
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calcium dynamics (Srinivasan et al., 2015). However, GCaMP6f should not be used as a calcium 
marker when studying LVGCCs, as this GECI has been recently shown to interfere with CaV1.2 
and CaV1.3 function (Yang et al., 2018). In their study, Yang et al. resolved these issues by 
developing the GCaMP-X sensor, which has since been successfully used for the study of 
LVGCC kinetics (Vierra et al., 2019). 
We presented data which further define spatial mapping patterns of CaV1.2 and CaV1.3 in 
neuronal cultures. In every case, these LVGCCs localized to dendrites (Fig. 5A and Fig. 5C). As 
mentioned previously, we expected not to observe fluorescence in the HA channel for wild-type 
neuronal cultures. However, we observed a positive PCC correlation for wild-type cultures in 
each sample. It is possible that the secondary antibodies used in this study were not specific 
enough to their respective primary antibody host species. In future experiments we plan to 
include both primary and secondary antibody control images, introduce conjugated antibodies for 
increased specificity, as well as perform single staining to account for unintentional fluorophore 
excitation from more than one channel. To further define LVGCC localization in culture, future 
ICC experiments should incorporate a cell body marker, such as postsynaptic density protein 95 
(PSD-95), and a microfilament marker, such as rhodamine phalloidin (F-actin marker). 
Another challenge we faced in our ICC experiment was the unavailability of antibodies 
specific enough to distinguish between CaV1.2 and CaV1.3 LVGCCs. To combat this, we 
targeted the HA epitope of either the CaV1.2-HA or CaV1.3-HA mouse model. While this method 
served the purpose of mapping an individual LVGCC expression pattern, it would be more 
beneficial to compare spatial mapping of both CaV1.2 and CaV1.3 in the same neuronal culture. 
Due to the lack of antibodies specific enough to achieve this goal, we have considered the 
generation of a new transgenic mouse line which expresses an endogenous fluorescent marker. 
Ideally, a useful approach would be to append enhanced green fluorescent protein (EGFP) to the 
Cacna1d gene. This would create the opportunity to analyze expression of CaV1.2-EGFP, while 
also allowing for visibility of CaV1.3-HA in the same culture (assuming the HA antibody used 
shows specificity). The caveat of this method is that the probability of generating a mouse line 
containing both LVGCC transgenes is very low, making this a very inefficient and costly 
process. It would still be useful to have a mouse model containing an endogenous fluorescent 
marker and no HA epitope, however, as this would yield high specificity of one LVGCC for 
spatial mapping. 
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It remains unclear if the hippocampal neuronal culture model in this study maintains 
CaV1.2 and CaV1.3 expression patterns representative of in-vivo findings. The ICC experiment 
presented here only considered transgenic over-expresser mouse models. It is possible that this 
genetic manipulation results in the addition of LVGCCs into cell regions where they would not 
normally localize in vivo. Furthermore, understanding the localization of CaV1.2 and CaV1.3 in 
neuronal cultures will allow us to verify if neuronal cultures are an accurate model of LVGCC 
expression patterns. Subsequent calcium imaging studies would then be possible at much higher 
spatial resolution, as we could narrow our focus to cell region-specific alterations of calcium 
dynamics. 
While the data reported in this study yield no significant differences in calcium dynamics 
between CaV1.2 and CaV1.3 LVGCCs, there is a consistent trend which prompts the 
consideration of future investigations. The observed decrease in calcium flux upon over-
expression of either LVGCC is counterintuitive. Similarly, the reciprocal relationship of LVGCC 
deletion and increased calcium transients is unexpected. A possible explanation for this pattern 
could be that genetic manipulations to these LVGCCs may result in a compensatory expression 
mechanism from the unmanipulated LVGCC. It has been shown that LVGCCs play a role in 
modulating gene expression (Misra et al., 1994), so it may be possible that there is an underlying 
cross-talk mechanism in which one LVGCC upregulates in response to deletion of another 
calcium channel. A protein microarray comparison experiment would serve to elucidate this 
postulation by measuring protein expression levels of both CaV1.2 and CaV1.3 under different 
genetic backgrounds. 
The importance of LVGCCs in physiological mechanisms underlying memory 
consolidation, development of neuropsychiatric disorders, and general neuronal function has 
been of great interest to the field in recent years. This study works to further the understanding of 
CaV1.2 and CaV1.3 calcium dynamics, specifically with regards to effects from LVGCC genetic 
mutations. While the data presented here do not directly establish a link between genetic 
mutation and altered calcium activity, there is a consistently observed reciprocal trend which 
demands the attention of future experiments. These LVGCCs are expressed in 
pathophysiologically relevant neural pathways, and further insight into the underlying molecular 
dynamics of this circuitry is critical. We have begun spatial characterization of a hippocampal 
neuronal culture model for altered expression levels of Cacna1c and Cacna1d. With highly 
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increased spatial resolution in neuronal cultures, subsequent experiments may shed light on 
physiological consequences of altered LVGCC gene expression. 
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